Table 3.

Comparison of 2-year cumulative mortality between MST and EVT.

Group	3 months (95%CI)	6 months (95%CI)	1 year (95%CI)	2 years (95%CI)
Before PSM
Total	27.7% (21.1–33.8%)	29.7% (22.9–35.9%)	30.4% (23.5–36.7%)	31.7% (24.7–38.1%)
MST	18.8% (11.0–25.9%)	20.0% (11.9–27.3%)	20.0% (11.9–27.3%)	21.2% (12.8–28.7%)
EVT	38.6% (27.5–48.0%)	41.6% (30.0–51.2%)	43.1% (31.3–52.8%)	44.6% (32.7–54.4%)
After PSM
Total	29.3% (19.1–38.3%)	30.9% (20.4–40.1%)	32.5% (21.6–41.8%)	34.1% (22.9–43.6%)
MST	32.3% (16.5–45.1%)	32.3% (16.5–45.1%)	32.3% (16.5–45.1%)	32.3% (16.5–45.1%)
EVT	26.7% (12.5–38.5%)	29.6% (14.6–42.0%)	32.5% (16.7–45.4%)	35.5% (18.9–48.6%)